Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Compass Pathways PLC (ADR) - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
CMPS
Nasdaq
8731
https://compasspathways.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Compass Pathways PLC (ADR)
Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression
- Apr 29th, 2024 10:30 am
Compass Pathways to participate in upcoming 23rd Annual Needham Virtual Healthcare Conference
- Apr 1st, 2024 8:01 pm
20 Most Depressed Countries in Asia
- Mar 31st, 2024 9:47 pm
Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors
- Mar 28th, 2024 12:00 pm
10 Alternatives to Antidepressant Medications
- Mar 10th, 2024 2:00 pm
15 Highest Paying Jobs with a Psychology Degree
- Mar 5th, 2024 2:59 pm
20 Countries with Most Antidepressant Users in the World
- Mar 5th, 2024 1:52 pm
COMPASS Pathways plc (NASDAQ:CMPS) Q4 2023 Earnings Call Transcript
- Mar 1st, 2024 2:08 pm
Compass Pathways Plc (CMPS) Q4 2023 Earnings Call Transcript
- Feb 29th, 2024 8:30 pm
Compass Pathways PLC Reports Increased Annual Net Loss Amid Clinical Advancements
- Feb 29th, 2024 12:34 pm
Compass Pathways Announces Fourth Quarter 2023 Financial Results and Business Highlights
- Feb 29th, 2024 12:00 pm
Penny Power Players: 3 Stocks to Watch in the Microcap Arena
- Feb 27th, 2024 5:33 pm
Compass Pathways to participate in upcoming TD Cowen investor conference
- Feb 26th, 2024 9:01 pm
Compass Pathways to announce fourth quarter and year-end 2023 financial results on February 29, 2024
- Feb 22nd, 2024 9:01 pm
Mental Health Mavericks: 3 Stocks Changing the Game
- Feb 21st, 2024 8:06 pm
Wall Street Says Compass Pathways Could Rise 307%. Here's How It Could Actually Happen.
- Feb 19th, 2024 12:00 pm
As investors pile into psychedelics, idealism gives way to pharma economics
- Feb 2nd, 2024 9:27 pm
Compass Pathways to participate in upcoming Oppenheimer investor conference
- Jan 31st, 2024 9:01 pm
Compass Pathways enters into research collaboration agreement with Hackensack Meridian Health to develop optimal clinical model for investigational COMP360 psilocybin treatment, if FDA-approved
- Jan 16th, 2024 1:00 pm
Therapy’s New Frontier: 3 Psychedelic Stocks for the Mental Health Revolution
- Jan 9th, 2024 6:56 pm
Scroll